Literature DB >> 16237479

Cannabinoids for the treatment of pain: an update on recent clinical trials.

Mark Ware1, Pierre Beaulieu.   

Abstract

Over the past five years, there has been a considerable increase in clinical research on cannabinoid use for a range of pain syndromes. Cannabinoid products are becoming available for research and clinical use, and pharmaceutical industry interest in the potential for cannabinoids in therapeutics is also gaining momentum. The present article summarizes recent clinical trial data in the field of pain management and suggests that the potential for cannabinoid therapy for chronic pain states is encouraging. Clinicians working in pain management should be aware of the options becoming available from the cannabinoid class of medications.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16237479     DOI: 10.1155/2005/847562

Source DB:  PubMed          Journal:  Pain Res Manag        ISSN: 1203-6765            Impact factor:   3.037


  7 in total

Review 1.  The pharmacotherapy of chronic pain: a review.

Authors:  Mary E Lynch; C Peter N Watson
Journal:  Pain Res Manag       Date:  2006       Impact factor: 3.037

Review 2.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

Review 3.  Recent advances in the pharmacological management of pain.

Authors:  Josée Guindon; Jean-Sébastien Walczak; Pierre Beaulieu
Journal:  Drugs       Date:  2007       Impact factor: 9.546

4.  Prevalence of Cannabinoid Use in Patients With Hip and Knee Osteoarthritis.

Authors:  David G Deckey; Nina J Lara; Matthew T Gulbrandsen; Jeffrey D Hassebrock; Mark J Spangehl; Joshua S Bingham
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2021-02-02

5.  Prevalence of Cannabinoid (CBD) Use in Orthopaedic Sports Medicine Patients.

Authors:  David G Deckey; Matthew Doan; Jeffrey D Hassebrock; Karan A Patel; Kostas Economopoulos; John M Tokish; Joshua S Bingham; Anikar Chhabra
Journal:  Orthop J Sports Med       Date:  2022-04-05

Review 6.  Cannabinoids in health and disease.

Authors:  Natalya M Kogan; Raphael Mechoulam
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

7.  Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2.

Authors:  Junran Xie; Dongju Xiao; Yun Xu; Jinning Zhao; Li Jiang; Xuming Hu; Yaping Zhang; Lina Yu
Journal:  Oncotarget       Date:  2016-02-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.